SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-14-066195
Filing Date
2014-11-10
Accepted
2014-11-10 06:05:39
Documents
11
Period of Report
2014-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q v392942_10q.htm 10-Q 473260
2 EXHIBIT 31.1 v392942_ex31-1.htm EX-31.1 8990
3 EXHIBIT 31.2 v392942_ex31-2.htm EX-31.2 9079
4 EXHIBIT 32.1 v392942_ex32-1.htm EX-32.1 5318
5 EXHIBIT 32.2 v392942_ex32-2.htm EX-32.2 5196
  Complete submission text file 0001144204-14-066195.txt   3970773

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE rgrx-20140930_cal.xml EX-101.CAL 21049
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE rgrx-20140930_def.xml EX-101.DEF 155864
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE rgrx-20140930_lab.xml EX-101.LAB 199412
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rgrx-20140930_pre.xml EX-101.PRE 185047
10 XBRL INSTANCE DOCUMENT rgrx-20140930.xml EX-101.INS 677177
11 XBRL TAXONOMY EXTENSION SCHEMA rgrx-20140930.xsd EX-101.SCH 31464
Mailing Address 15245 SHADY GROVE ROAD SUITE 470 ROCKVILLE MD 20850
Business Address 15245 SHADY GROVE ROAD SUITE 470 ROCKVILLE MD 20850 301-208-9191
REGENERX BIOPHARMACEUTICALS INC (Filer) CIK: 0000707511 (see all company filings)

IRS No.: 521253406 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-15070 | Film No.: 141206466
SIC: 2834 Pharmaceutical Preparations